Browse by Poster Author

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Browse by Poster Author

Type here to filter the list

D
D’Andrea, Elvira

Global Epidemiology, AbbVie Inc.
(038) Unlocking Insights: Lesson Learned from the Tokenization of a Psoriasis Trial
Elvira D’Andrea
Favorite
(055) Measuring the Use of TNF-alpha Inhibitors in Patients with Ulcerative Colitis: Optimization of Washout Period Duration and Observability
Elvira D’Andrea
Favorite
D’Onofrio, Brian

Department of Psychological and Brain Sciences, Indiana University, Bloomington, USA
(BSPOT22) Associations between Dose of Prescribed Opioid Analgesic Exposure During Pregnancy and Adverse Birth Outcomes and Early Mortality: A Population-Based Study
Brian D’Onofrio
Favorite
(BSPOT40) Incident benzodiazepine and Z-drug use and subsequent risk of serious infections
Brian D’Onofrio
Favorite
Da Cas, Roberto

Italian National Institute of Health
(120) How much frequently are biological drugs used in patients over 65 years with immune-mediated inflammatory diseases through the Italian VALORE distributed database network
Roberto Da Cas
Favorite
(292) The role of Rheumatic Diseases in the relationship between mRNA vaccines and Myocarditis/Pericarditis in a cohort of Italian vaccinees: TheShinISS-Vax Study
Roberto Da Cas
Favorite
da Purificação Costa, Ana Carolina

Universidade Estadual de Campinas
(295) Use of antibacterials and suspected acute renal failure in Brazil: pharmacovigilance analysis, 2018-2023
Ana Carolina da Purificação Costa
Favorite
Da Silva Oliveira, Douglas

Federal University of Bahia
(CSPOT22) Biologic Drugs Use In Inflammatory Bowel Diseases: A Systematic Review And Meta-Analysis
Douglas Da Silva Oliveira
Favorite
da Silva Pereira Curado, Daniel

Ministry of Health, Distrito Federal, Brasília, Brazil.
(298) Are Costs Decisive in the Incorporation of Medicines for the Treatment of Ultra-rare Diseases in Brazil? Trends in Healthcare Coverage for Ultra-rare Diseases
Daniel da Silva Pereira Curado
Favorite
(BSPOT36) Assessing Clinical Evidence for the Incorporation of Technologies in Ultra-rare Diseases in Brazil: A Decade of CONITEC Reports
Daniel da Silva Pereira Curado
Favorite
D’Angelo, Robert

Beth Israel Deaconess Medical Center | Harvard Medical School
(183) Outcomes of antiarrythmic drugs versus catheter ablation for treatment of atrial fibrillation in an elderly population
Robert D’Angelo
Favorite
D’Avila, Andre

Beth Israel Deaconess Medical Center | Harvard Medical School
(183) Outcomes of antiarrythmic drugs versus catheter ablation for treatment of atrial fibrillation in an elderly population
Andre D’Avila
Favorite
Díaz, Karina

University of Chile
(353) Serious Neurological Adverse Reactions to SARS-CoV-2 Vaccines in Chile
Karina Díaz
Favorite
Dabbous, Firas

Evidera | PPD, Inc.
(174) Standardization of Coding Definitions for Sickle Cell Disease Complications: A Systematic Literature Review
Firas Dabbous
Favorite
Dagan, Noa

Clalit Research Institute, Innovation Division, Clalit Health Services
(088) Capturing Information Not Presented in Hazard Ratios: The Added Value of Presenting Plots of Instantaneous Hazards for Time-To-Event Analyses
Noa Dagan
Favorite
Dagenais, Pierre

Université de Sherbrooke
(219) What motivates patients with chronic musculoskeletal pain to use medical cannabis as a treatment strategy? Results from a questionnaire study.
Pierre Dagenais
Favorite
Dahlén, Elin

Department of Pharmacoepidemiology and analysis, Swedish Medical Products Agency, Uppsala, Sweden.
(234) Dosing of antidepressants in relation to body weight in children and adolescents with overweight and obesity- a population-based study
Elin Dahlén
Favorite
(236) Increased Prescribing of Neuroleptics to Children in Sweden
Elin Dahlén
Favorite
Dahl, Marja-Liisa

Division of Clinical Pharmacology, Department of Laboratory Medicine, Karolinska Institutet, Karolinska University Hospital, Huddinge, Stockholm, Sweden.
(189) Risk identification based on prescribed drugs and comorbidities in patients with Torsade de pointes arrhythmia – a population-based Swedish cohort study.
Marja-Liisa Dahl
Favorite
Dahlqvist, Tanja

Pharmacoepidemiology, Department of Pharmacy, Uppsala University, 752 36 Uppsala, Sweden
(027) More-EUROPA (More Effectively Using Registries) – A cross-sectional survey assessing evidence needs around the introduction of new medicines
Tanja Dahlqvist
Favorite
Daida, Yihe

Center for Integrated Health Care Research, Kaiser Permanente Hawaii
(123) Racial and language disparities in initial COVID-19 vaccination during lactation
Yihe Daida
Favorite
(262) Antidepressant and Psychotherapy Initiation Among Patients with New Episodes of Depression During Pregnancy
Yihe Daida
Favorite
(274) Language and racial disparities in initial COVID-19 vaccination during pregnancy
Yihe Daida
Favorite
(355) Tetanus, Diphtheria, Pertussis (Tdap) Vaccination During Pregnancy and Initiation of Human Milk Feeding
Yihe Daida
Favorite
Daiello, Lori

Department of Health Services, Policy, and Practice, Brown University School of Public Health, Providence, Rhode Island
(110) Evaluating Lecanemab Eligibility for Patients in Skilled Nursing Facilities with Alzheimer's Disease or Mild Cognitive Impairment
Lori Daiello
Favorite
Dalby, Helene

Department of Clinical Epidemiology, Department of Clinical Medicine, Aarhus University and Aarhus University Hospital
(058) Surgery for Chronic Diverticular Disease - Incidence and Predictors
Helene Dalby
Favorite
Dalhoff, Kim

Department of Clinical Pharmacology, Copenhagen University Hospital - Bispebjerg and Frederiksberg
(021) Ischemic Cardiotoxicity of Aromatase Inhibitors in Postmenopausal Women with Early Breast Cancer: an Analysis of Real-World Data
Kim Dalhoff
Favorite
Dallaire, Clémence

Université Laval
(286) Description of interventions performed by pharmacists involved in the care of older adults with neurocognitive disorders in family medicine groups in Quebec, Canada
Clémence Dallaire
Favorite
Dalle Lucca, Jurandir

White River Junction Veterans Affairs Medical Center
(342) Final Results from Post-Emergency Use Authorization (EUA) Active Safety Surveillance Study among Individuals in the Veterans Affairs Health System Receiving Pfizer-BioNTech Coronavirus Disease 2019 (COVID-19) Vaccine
Jurandir Dalle Lucca
Favorite
Dalton, Susanne

Cancer Survivorship, Danish Cancer Institute, Copenhagen, Denmark
(030) The impact of Body Mass Index on colorectal cancer prognosis. A population-based cohort study in Denmark.
Susanne Dalton
Favorite
Daltveit, Anne Kjersti Nesje

Department of Global Public Health and Primary Care, University of Bergen
(273) Gabapentin in Pregnancy and Birth Outcomes: a Population-based Prevalence Study in Nordic Countries (EUPAS38620)
Anne Kjersti Nesje Daltveit
Favorite
Damase-Michel, Christine

CERPOP, Inserm U1295, Université de Toulouse Paul Sabatier, Service de Pharmacologie Clinique, CHU de Toulouse
(260) A systematic review of gabapentinoids use during pregnancy and effects on pregnancy and childhood outcomes: an IMI ConcePTION study
Christine Damase-Michel
Favorite
(275) Gabapentinoids exposure in early pregnancy and risk of congenital anomalies: an IMI ConcePTION European case-malformed control study
Christine Damase-Michel
Favorite
(282) Reason for gabapentinoids prescribing in pregnancy: results from five European countries. A contribution from the IMI ConcePTION project
Christine Damase-Michel
Favorite
(310) Risk of congenital ocular anomaly in EUROmediCAT: Assessment of the Potential Risk of Taking Medications during Pregnancy in Europe.
Christine Damase-Michel
Favorite
(313) Specific congenital anomalies associated with maternal Multiple Sclerosis: A ConcePTION European case-malformed control study
Christine Damase-Michel
Favorite
(318) The occurrence of specific congenital anomalies associated with maternal Systemic Lupus Erythematosus: A ConcePTION Case-malformed control study in EUROmediCAT
Christine Damase-Michel
Favorite
(BSPOT23) Evaluating performance and methodologies of machine learning and conventional pharmacoepidemiologic modeling to identify pregnant individuals at risk of giving birth to children with major congenital malformations
Christine Damase-Michel
Favorite
(BSPOT37) Identifying women of childbearing age with Multiple Sclerosis in six European healthcare data sources - A contribution from the IMI-ConcePTION project
Christine Damase-Michel
Favorite
Damkier, Per

Department of Clinical Pharmacology, Odense University Hospital, Odense, Denmark
(031) The relation between tamoxifen metabolism and time to discontinuation: A Bayesian pathway analysis in premenopausal breast cancer patients
Per Damkier
Favorite
Dampf, Hana

University of Alberta
(084) Trends in Central Nervous System Medication Use among Assisted Living Residents with Cognitive Impairment: Variation by Presence of Dementia Care and the COVID-19 Pandemic
Hana Dampf
Favorite
Daniels, Benjamin

UNSW Sydney
(175) The Use and Implementation of Instrumental Variables in Pharmacoepidemiology: A Scoping Review
Benjamin Daniels
Favorite
(203) Medicine utilisation studies in Australian individual-level dispensing data: A blinded, multi-centre replication experiment
Benjamin Daniels
Favorite
Daniel, Shoshana

RWE & Analytics, Market Access Consulting & HEOR, Fortrea, Israel
(189) Improving the Role of External Control Arms in Early-Phase Single Arm Trials
Shoshana Daniel
Favorite
Daniels, Kimberly

Carelon Research
(347) Interim Utilization Results from a Post-Approval Safety Study of Pfizer-BioNTech Monovalent COVID-19 Vaccine in the United States
Kimberly Daniels
Favorite
Daniels, Michael

University of Florida
(067) Clinical outcomes of discontinuing long-term opioid therapy among older cancer survivors in nursing homes
Michael Daniels
Favorite
(ASPOT41) Clinical and Adverse Outcomes Associated with Concomitant Use of CYP2D6-metabolized Opioids with Antidepressants in Older Nursing Home Residents—A Retrospective Cohort Study
Michael Daniels
Favorite
Danielsson, Bengt

Division of Clinical Pharmacology, Department of Laboratory Medicine, Karolinska Institutet, Karolinska University Hospital, Huddinge, Stockholm, Sweden.
(189) Risk identification based on prescribed drugs and comorbidities in patients with Torsade de pointes arrhythmia – a population-based Swedish cohort study.
Bengt Danielsson
Favorite
Danker, Walter

Johnson & Johnson
(151) Clinical and Economic Outcomes of Cesarean Deliveries with Skin Closure through Conventional Sutures Plus Waterproof Wound Dressings versus 2-octyl Cyanoacrylate Plus Polymer Mesh Tape
Walter Danker
Favorite
Danysh, Heather

RTI Health Solutions
(178) Validation of Algorithms to Identify Breast Cancer and Bladder Cancer Among Patients With Type 2 Diabetes Mellitus in United States Medicare Administrative Claims
Heather Danysh
Favorite
Dao, Kim

Swiss Teratogen Information Service and Clinical Pharmacology Service, Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne, Lausanne, Switzerland
(308) Reproductive safety of glucagon-like peptide 1 receptor agonists (GLP1-RA) after maternal exposure in early pregnancy: a comparative ENTIS cohort study
Kim Dao
Favorite
D'Arbeloff, Tracy

OMNY Health
(086) Applying Natural Language Processing of Clinical Notes to Determine Social Determinant Risk Factor Status for Patients Receiving Glucagon-Like Peptide-1 Agonist Treatment
Tracy D'Arbeloff
Favorite
Dareng, Eileen

Astra Zeneca
(325) Use of population-based real world data sources and disease specific registries to conduct post approval pregnancy safety studies for a biologic indicated for a complex, uncommon indication - challenges and opportunities
Eileen Dareng
Favorite
Darnaude-Ximénez, Ignacio

Clinical Pharmacology Department. Puerta de Hierro Hospital
(249) The importance of the analysis of multiple databanks for the valid estimation of thrombocytopenia incidence rates in children in BIFAP data source (Spain).
Ignacio Darnaude-Ximénez
Favorite
Das, Biswadeep

All India Institute of Medical Sciences(AIIMS) Rishikesh
(111) Evaluation of QT Prolonging Drug Use Among Elderly with Psychiatric Disorders in India using Beers Criteria(2019) and STOPP Criteria(2015)
Biswadeep Das
Favorite
(231) Adverse drug reactions due to antitubercular therapy in multidrug resistant tuberculosis in North east India
Biswadeep Das
Favorite
Dashevsky, Inna

Department of Population Medicine, Harvard Pilgrim Health Care Institute
(248) Surveillance of outcomes identified with use of biologics indicated for asthma: a comparison of events observed with pediatric utilization
Inna Dashevsky
Favorite
(265) Finding the Forest in the TreeScan: A Big Data Driven Approach to Screening Drug Use in Pregnancy
Inna Dashevsky
Favorite
Das, Saibal

Department of Global Public Health, Karolinska Institutet, Stockholm, Sweden and Indian Council of Medical Research - Centre for Ageing and Mental Health, Kolkata, India
(134) Prevalence and factors associated with polypharmacy and self-medication among the elderly population residing in urban Indian communities
Saibal Das
Favorite
(218) Perceptions on treatment utilization and risk of overdose among opioid users in Kolkata: A qualitative study
Saibal Das
Favorite
Datta-Nemdharry, Preeti

MHRA
(329) Using Real-World Data to Quantify the Rate of Unintended Pregnancies and Specified Adverse Events in Women Prescribed Oral Levonorgestrel 30µg or Levonorgestrel Implant
Preeti Datta-Nemdharry
Favorite
Dave, Chintan

Rutgers University
(020) Initiation Trends of Disease-Modifying Antirheumatic Drugs for Rheumatoid Arthritis Among Adults in the United States from 2001 to 2021
Chintan Dave
Favorite
(042) Comparative risk of lactic acidosis associated with initiation of metformin among patients with and without renal impairment
Chintan Dave
Favorite
(254) Trends in New Use of Disease-Modifying Antirheumatic Drugs Among Children with Juvenile Idiopathic Arthritis in the United States, 2001-2022
Chintan Dave
Favorite
David, Bates

Harvard Medical School
(331) Comparative risk of mortality in new users of prescription opioids for non-cancer pain: results from the International Pharmacosurveillence Study
Bates David
Favorite
David, Pierre-Marie

Université de Montréal
(014) Experiences and perceptions of patients and healthcare professionals with advanced practice partnership agreements between Family Medicine Group pharmacists and healthcare professionals
Pierre-Marie David
Favorite
Davidson, Jennifer A.

CorEvitas, UK Research, Specialty EMR Data
(303) Estimation of period-based costs associated with individual chronic complications of rare inherited diseases, in the context of multimorbidity, using real-world data.
Jennifer A. Davidson
Favorite
Davies, Miranda

Drug Safety Research Unit, Southampton, UK
(333) Case Series Analysis of Immune-Mediated Neurological Events in Vaccinees following AZD1222 (ChAdOx1 nCoV-19): Results from a UK Post-authorisation Active Surveillance Study
Miranda Davies
Favorite
(338) Cumulative Rates of Serious and Adverse Events of Special Interest in Vaccinees Following AZD1222 (ChAdOx1 nCoV-19): Results from a UK Post-authorisation Active Surveillance Study
Miranda Davies
Favorite
(349) Observed versus Expected Analysis of Adverse Events of Special Interest after AZD1222 (ChAdOx1 nCoV-19) Vaccination: Results from a UK Post-authorisation Active Surveillance Study
Miranda Davies
Favorite
Davies, Neil

University College London
(159) Insomnia Symptom Prevalence in England: A Comparison of Self-Reported Data and Primary Care Records in the UK Biobank
Neil Davies
Favorite
Davies, Rhian

Jumping Rivers Ltd
(317) Use of European rare disease registries to describe the natural history and disease progression of Spinal Muscular Atrophy (SMA) over time
Rhian Davies
Favorite
Davis, Daniel

University College London
(088) Antidepressants and Risk of Orthostatic Hypotension: a Self-Controlled Case Series Study
Daniel Davis
Favorite
Davis, Libby

Vanderbilt University
(072) Patterns of Underreporting of Enrollment Dates in Cancer Clinical Trials: A HemOnc Knowledgebase Analysis
Libby Davis
Favorite
Davis, Ryan

Genentech
(077) Replication of overall response in mNSCLC patients treated with pembrolizumab and chemotherapy using RECIST 1.1 criteria applied to images from the real world
Ryan Davis
Favorite
Davoli, Marina

Department of Epidemiology, ASL Roma1, SSR Lazio, Rome, Italy
(121) Mortality associated with use of etelcalcetide versus cinacalcet for the treatment of secondary hyperparathyroidism in patients in haemodialysis: a population based study in Lazio, Italy
Marina Davoli
Favorite
Davy-Mendez, Thibaut

University of North Carolina at Chapel Hill
(CSPOT02) Gender Differences in Statin Persistence across Racial and Ethnic Groups among Persons with HIV in the United States
Thibaut Davy-Mendez
Favorite
Dawood, Halima

Greys Hospital, KwaZulu-Natal
(BSPOT51) Signal Monitoring for Adverse Events Following Immunization with COVID-19 Vaccines During the SARS-CoV-2 Pandemic: An Evaluation of the South African Surveillance System
Halima Dawood
Favorite
Dawwas, Ghadeer

Vanderbilt University School of Medicine
(125) Risk of Acute Kidney Injury with Direct Oral Anticoagulants Compared with Warfarin: Population-based analysis.
Ghadeer Dawwas
Favorite
De Belder, Mark

National Institute of Cardiovascular Outcomes Research (NICOR), NHS Arden and Greater East Midlands Commissioning Support Unit, Leicester, UK
(059) Fluoropyrimidine chemotherapy and the risk of death and cardiovascular events in patients with gastrointestinal cancer: a cohort study
Mark De Belder
Favorite
de Bock, Geertruida

Department of Epidemiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
(098) Dispensing Patterns of Inhaled Asthma Medication Before and During COVID-19 Among Young Adults: A Retrospective Inception Cohort Study
Geertruida de Bock
Favorite
De Bruijn, Adrie

National Institute for Public Health and the Environment (RIVM)
(CSPOT32) Impact of risk communication on thrombosis with thrombocytopenia syndrome for COVID-19 adenovirus vector vaccines on European healthcare professionals
Adrie De Bruijn
Favorite
De Bruin, Marie

Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands.
(CSPOT43) Risk Management of Authorised Advanced Therapy Medicinal Products in the EU
Marie De Bruin
Favorite
de Bruin, Odette

Department of Obstetrics, Division Woman and Baby, Wilhelmina Children’s Hospital, University Medical Center Utrecht (UMCU), Utrecht, the Netherlands
(288) Patterns of Prescribed and Dispensed Medicines among Non-Hospitalized Pregnant women with COVID-19: a Prospective Meta-analysis pooling findings from Healthcare Databases in Europe and North America
Odette de Bruin
Favorite
(304) Prevalence of medication use for COVID-19 treatment in pregnancy: a two-stage individual patient data meta-analysis combining international registries.
Odette de Bruin
Favorite
de Feijter, Maud

Netherlands Pharmacovigilance Centre Lareb, ’s-Hertogenbosch, the Netherlands
(293) Predictors for correct vitamin D intake among pregnant women in the Netherlands
Maud de Feijter
Favorite
(314) The association between COVID-19 vaccination during pregnancy and neonatal health outcomes
Maud de Feijter
Favorite
De Gevigney, Guy

Department of Cardiology, Hôpital Louis-Pradel, Hospices Civils de Lyon, Lyon, France
(BSPOT15) Transcatheter and Surgical Aortic Valve Implantation in the Management of Aortic Stenosis between 2010 and 2022: a French Nationwide Study
Guy De Gevigney
Favorite
De Jong, Valentijn

European Medicines Agency
(148) Association between incident interstitial lung disease with direct oral anticoagulants compared to warfarin users: Multi-database cohort study
Valentijn De Jong
Favorite
de Lange, Melanie

University of Bristol
(159) Insomnia Symptom Prevalence in England: A Comparison of Self-Reported Data and Primary Care Records in the UK Biobank
Melanie de Lange
Favorite
De Leacy, Reade

Mount Sinai Hospital, Department of Neurosurgery
(159) Readmission Rates and Costs Associated with the Use of Enterprise 2 and Neuroform Atlas Stents for Unruptured Intracranial Aneurysms: A Comparative Real-World Analysis
Reade De Leacy
Favorite
De Lemus Belmonte, Mencia

SMA Europe
(317) Use of European rare disease registries to describe the natural history and disease progression of Spinal Muscular Atrophy (SMA) over time
Mencia De Lemus Belmonte
Favorite
De Luca, Giulia

Unit of Pharmacology and Pharmacovigilance, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy
(037) Switching proportion assessment in rheumatoid arthritis patients exposed to disease modifying anti-rheumatic drugs: systematic review and meta-analysis
Giulia De Luca
Favorite
de Luise, Cynthia

Pfizer, Inc., New York, NY, USA
(342) Final Results from Post-Emergency Use Authorization (EUA) Active Safety Surveillance Study among Individuals in the Veterans Affairs Health System Receiving Pfizer-BioNTech Coronavirus Disease 2019 (COVID-19) Vaccine
Cynthia de Luise
Favorite
(344) Interim results from the VAC4EU Post-Authorization Safety Study (PASS) among recipients of the Pfizer-BioNTech COVID-19 (Comirnaty®) vaccine in Europe
Cynthia de Luise
Favorite
de Lusignan, Simon

University of Oxford
(336) Comparing disparities in uptake of COVID-19 and influenza vaccination among pregnant women, September 2020 and March 2022: English and Welsh national cohorts
Simon de Lusignan
Favorite
(340) Epidemiology of Thrombotic Thrombocytopenia Syndrome before, during and post COVID-19 pandemic: English sentinel network cohort studies
Simon de Lusignan
Favorite
(353) Rare adverse events of interest following vaccination: Strengths and weaknesses of a national data resource compared to the national sentinel network database
Simon de Lusignan
Favorite
de Munter, Leonie

P95 Epidemiology & Pharmacovigilance
(352) Quantifying Bias in COVID-19 Vaccine Effectiveness (VE) Estimates Due to Missing Information on Prior SARS-CoV-2 Infection: an Assessment Using Data from the European COVIDRIVE Study
Leonie de Munter
Favorite
de Paula de Sordi, Mônica Aparecida

Health Technology Assessment, Hospital das Clínicas da Faculdade de Medicina de Botucatu (HCFMB), Botucatu, São Paulo, Brazil
(298) Are Costs Decisive in the Incorporation of Medicines for the Treatment of Ultra-rare Diseases in Brazil? Trends in Healthcare Coverage for Ultra-rare Diseases
Mônica Aparecida de Paula de Sordi
Favorite
(BSPOT36) Assessing Clinical Evidence for the Incorporation of Technologies in Ultra-rare Diseases in Brazil: A Decade of CONITEC Reports
Mônica Aparecida de Paula de Sordi
Favorite
De Paula, Waléria

Federal University of Ouro Preto
(115) Factors associated with potentially inappropriate medicines use in older adults during the covid-19 pandemic in two Brazilian municipalities: a cross-sectional study
Waléria De Paula
Favorite
De Pieri, Marica

Division of Pediatric Infectious Diseases, Department for Woman’s and Child’s Health, University of Padua, Padua, Italy
(284) Retrospective Cross-Sectional Study Assessing Adverse Events And Treatment Failure In Pediatric Hemato-Oncological Patients Receiving Posaconazole (Off-label) Or Liposomal Amphotericin B Prophylaxis
Marica De Pieri
Favorite
De Sarro, Giovambattista

University “Magna Graciae” of Catanzaro, Catanzaro, Italy
(120) How much frequently are biological drugs used in patients over 65 years with immune-mediated inflammatory diseases through the Italian VALORE distributed database network
Giovambattista De Sarro
Favorite
De Souza Teles Santos, Carlos Antonio

Federal University of Bahia
(057) Spatial-Temporal Patterns In Biologic Prescriptions For Inflammatory Bowel Diseases In The Public Healthcare System In Brazil
Carlos Antonio De Souza Teles Santos
Favorite
(CSPOT18) Socioeconomic Conditions Effects On Biological Prescriptions For Inflammatory Bowel Disease In Brazil
Carlos Antonio De Souza Teles Santos
Favorite
(CSPOT22) Biologic Drugs Use In Inflammatory Bowel Diseases: A Systematic Review And Meta-Analysis
Carlos Antonio De Souza Teles Santos
Favorite
de Vol, Edward

Department of Biostatistics, Epidemiology and scientific computing, King Faisal Specialist Hospital
(016) Empirical Estimation of Hepatocellular Carcinoma Prevalence in Saudi Arabia: A Gender and Age Group Analysis
Edward de Vol
Favorite
De Vos, Maarten

Department of Electrical Engineering (ESAT), KU Leuven, Belgium
(315) The BELpREG Registry on Perinatal Medication Exposure and Mother-Infant Outcomes: Preliminary Insights into this unique Pregnancy Cohort in Belgium
Maarten De Vos
Favorite
de Vos, Stijn

PharmacoTherapy, -Epidemiology and -Economics, Groningen Research Institute of Pharmacy, University of Groningen, 9713 AV Groningen, The Netherlands
(049) Hypoglycaemia Risk and Medication De-intensification in Diabetes Patients: A Cohort Study
Stijn de Vos
Favorite
(071) Sex Disparities in Medication Changes After Metformin Initiation are Associated With Small, Clinically Non-Relevant, Sex Differences in HbA1c Levels During Follow-up
Stijn de Vos
Favorite
(083) A Case-control Study On Polypharmacy And Co-medications in Alzheimer’s Disease
Stijn de Vos
Favorite
(157) Comparative effectiveness of anti-hyperlipidemic drugs monotherapy in primary prevention of cardiovascular disease
Stijn de Vos
Favorite
de Vries, Corinne

European Medicines Agency
(288) Patterns of Prescribed and Dispensed Medicines among Non-Hospitalized Pregnant women with COVID-19: a Prospective Meta-analysis pooling findings from Healthcare Databases in Europe and North America
Corinne de Vries
Favorite
de Vries, Esther

Medicines Evaluation Board, Utrecht, the Netherlands
(CSPOT28) Limited impact of Direct Healthcare Professional Communications when using optimal outcomes and appropriate study populations: a systematic review.
Esther de Vries
Favorite
de Vries, Femke

University of Groningen, University Medical Center Groningen, Department of Clinical Pharmacy and Pharmacology, Groningen, Netherlands
(CSPOT31) Perspectives of People With Type 2 Diabetes Mellitus Towards a Decision Aid Assessing Preferences of Glucose-Lowering Drugs: The Dilemma of Choosing
Femke de Vries
Favorite
de Vries, Folgerdiena

German Center for Neurodegenrative Diseases
(211) Prevalence of Medication-Related Risk Factors for Adverse Drug Reactions
Folgerdiena de Vries
Favorite
de Vries, Sieta T.

Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands
(027) More-EUROPA (More Effectively Using Registries) – A cross-sectional survey assessing evidence needs around the introduction of new medicines
Sieta T. de Vries
Favorite
(071) Sex Disparities in Medication Changes After Metformin Initiation are Associated With Small, Clinically Non-Relevant, Sex Differences in HbA1c Levels During Follow-up
Sieta T. de Vries
Favorite
(291) Interest in Use of a Mobile App for Reporting Adverse Drug Reactions: A Survey Study Among Healthcare Professionals and the Public in Indonesia
Sieta T. de Vries
Favorite
(352) Views on The Development and Use of a New Digital Health Platform to Improve Adverse Drug Event Detection, Management and Reporting in Australia: A Qualitative Study
Sieta T. de Vries
Favorite
(BSPOT03) Advancing Health Equity in Europe: A Framework of Diversity and Fairness in Pharmacoepidemiologic Research
Sieta T. de Vries
Favorite
(CSPOT31) Perspectives of People With Type 2 Diabetes Mellitus Towards a Decision Aid Assessing Preferences of Glucose-Lowering Drugs: The Dilemma of Choosing
Sieta T. de Vries
Favorite
de Wilde, Marcel

Erasmus University Medical Center, Rotterdam, The Netherlands
(345) Medication Errors in EudraVigilance: Signals of Disproportionate Reporting Among Age Groups
Marcel de Wilde
Favorite
Dea, Katherine

STATLOG
(347) Interim Utilization Results from a Post-Approval Safety Study of Pfizer-BioNTech Monovalent COVID-19 Vaccine in the United States
Katherine Dea
Favorite
Dean, Alex

Veradigm LLC
(337) Defining a Post-vaccine Myocarditis Cohort by Applying CDC Case Definition to Structured EHR and Claims Data as a Proxy for Case Adjudication
Alex Dean
Favorite
Deanfield, John

Institute of Cardiovascular Science, University College London, United Kingdom
(059) Fluoropyrimidine chemotherapy and the risk of death and cardiovascular events in patients with gastrointestinal cancer: a cohort study
John Deanfield
Favorite
Debette, Stéphanie

Univ. Bordeaux, INSERM, BPH, U1219, équipe ELEANOR, Bordeaux (France); CHU de Bordeaux, Pôle de neurosciences cliniques, Service de neurologie, Bordeaux (France)
(048) Antiangiogenic Drugs and the Risk of Arterial Dissection or Aneurysm in Patients with Metastatic Colorectal Cancer
Stéphanie Debette
Favorite
Debieuvre, Didier

Pneumology Department, Groupe Hospitalier Mulhouse Sud-Alsace, Mulhouse, France
(011) Characteristics and treatment sequences of patients with KRAS G12C, other KRAS and KRAS-wild-type advanced or metastatic (AM) Non-Small Cell Lung Cancer (NSCLC) in the French ESME cohort
Didier Debieuvre
Favorite
Debnath, Ronita

Mu Sigma
(157) Postoperative Clinical and Economic Outcomes of Patients with Reverse or Anatomic Total Shoulder Arthroplasty at One Year: A Retrospective, United States Hospital Billing Database Analysis
Ronita Debnath
Favorite
Dedman, Daniel

Clinical Practice Research Datalink (CPRD), Medicines and Healthcare Products Regulatory Agency
(124) Incidence and Complications of Rectopexy in the United Kingdom and United States, 2013-2022.
Daniel Dedman
Favorite
(138) The risks of immune- and inflammatory related post-acute sequelae of COVID-19: a network study in 6 European countries, the US, and Korea
Daniel Dedman
Favorite
(297) Use of systemic fluoroquinolones in primary care and hospital settings in the UK: A population-level cohort study
Daniel Dedman
Favorite
Deeb, Mohammed

Walgreens Real World Evidence Clinical Trials
(053) Identification of Cohorts for Ulcerative Colitis, Diabetes, and Small Cell Lung Cancer With Corresponding Demographic and Geographic Distributions From a Nationally Representative U.S. Pharmacy Database
Mohammed Deeb
Favorite
(090) Characteristics of Initial Prescription Dispensations Among Individuals Newly Prescribed GLP-1 Medications in a National Retail Pharmacy Database
Mohammed Deeb
Favorite
Deenen, Maarten

Department of Clinical Pharmacy, Catharina Hospital, Eindhoven, the Netherlands
(055) Development and portability of a text mining algorithm for capturing disease progression in electronic health records of with stage IV non-small cell lung cancer treated with immuno-chemotherapy
Maarten Deenen
Favorite
Deeter, Jamie

Roche Diagnostics International
(241) Clinical manifestations, complications, and healthcare utilization of adult outpatients with RSV infection in the United States: a retrospective real-word study
Jamie Deeter
Favorite
DeFor, Terese

HealthPartners Institute
(316) The IMEDS Distributed Database Network and Pregnancy Studies
Terese DeFor
Favorite
(347) Interim Utilization Results from a Post-Approval Safety Study of Pfizer-BioNTech Monovalent COVID-19 Vaccine in the United States
Terese DeFor
Favorite
Degefaw, Desalegne

Ohio State Global One Health
(331) Applicability of Selected Brighton Collaboration Case Definitions in Prospective Hospital-Based Safety Surveillance for Covid-19 Vaccines, Addis Ababa, Ethiopia
Desalegne Degefaw
Favorite
Degenhardt, Louisa

UNSW Sydney
(200) Age-related risk of serious fall events associated with opioid analgesic use
Louisa Degenhardt
Favorite
(210) Long-term prescribed opioid use after hospitalisation or emergency department presentation among opioid-naïve adults in New South Wales (NSW), Australia (2014–2020)—a population-based cohort study
Louisa Degenhardt
Favorite
Degen, Miriam

Division of Clinical Epidemiology and Aging Research, German Cancer Research Center
(132) Polypharmacy and Potentially Inadequate Medication in Older Adults: Results from the German National Cohort (NAKO) Baseline.
Miriam Degen
Favorite
(317) Psychotropic medicine use in the German National Cohort (NAKO) baseline
Miriam Degen
Favorite
Dehghan Tarazjani, Amirreza

Department of Data Science and Biostatistics, Julius Center, University Medical Center Utrecht
(349) Patient-level prognostic models for COVID-19 vaccine effectiveness and safety: a systematic review
Amirreza Dehghan Tarazjani
Favorite
DeKosky, Steven

University of Florida
(067) Clinical outcomes of discontinuing long-term opioid therapy among older cancer survivors in nursing homes
Steven DeKosky
Favorite
(ASPOT41) Clinical and Adverse Outcomes Associated with Concomitant Use of CYP2D6-metabolized Opioids with Antidepressants in Older Nursing Home Residents—A Retrospective Cohort Study
Steven DeKosky
Favorite
Delaney, Joseph

University of Washington
(263) Antiseizure medication use during pregnancy and the Risk of adverse neonatal birth outcomes in two Canadian provinces
Joseph Delaney
Favorite
(274) Gabapentin Use During Pregnancy and the Risk of Adverse Neonatal Birth Outcomes in two Canadian provinces
Joseph Delaney
Favorite
Delcher, Chris

University of Kentucky College of Pharmacy
(226) Prevalence and sociodemographic characteristics of people with prescription stimulant use disorder: results from the National Survey on Drug Use and Health, 2015-2019
Chris Delcher
Favorite
Deligianni, Elena

Democritus University of Thrace
(CSPOT32) Impact of risk communication on thrombosis with thrombocytopenia syndrome for COVID-19 adenovirus vector vaccines on European healthcare professionals
Elena Deligianni
Favorite
Dell'Aniello, Sophie

Lady Davis Institute of the Jewish General Hospital
(209) What Exactly Does Clone-Censor-Weighting Estimate When Studying Treatment Initiation Windows, Anyway?
Sophie Dell'Aniello
Favorite
Dell'Anna, Lucia

Division of Pediatric Infectious Diseases, Department for Woman’s and Child’s Health, University of Padua, Padua, Italy
(284) Retrospective Cross-Sectional Study Assessing Adverse Events And Treatment Failure In Pediatric Hemato-Oncological Patients Receiving Posaconazole (Off-label) Or Liposomal Amphotericin B Prophylaxis
Lucia Dell'Anna
Favorite
Delmestri, Antonella

University of Oxford
(029) Prevalence of dermatomyositis and polymyositis in adults and paediatric populations: a network cohort study part of DARWIN EU®
Antonella Delmestri
Favorite
(071) Discontinuation of bisphosphonates in older people with complex health needs: self-controlled case series to assess fracture risk
Antonella Delmestri
Favorite
(077) Large scale propensity score matching with time-stratification in older women with or without fractures in the UK
Antonella Delmestri
Favorite
(116) Feasibility of a Federated Network Analysis Using Real-World Data Mapped to OMOP Common Data Model to Estimate Healthcare Resource Utilisation and Costs of Imminent Subsequent Fracture
Antonella Delmestri
Favorite
(135) Primary Care Resource Utilisation and Costs of Fragility Fractures in Postmenopausal Women in the UK Using CPRD Data Mapped to OMOP Common Data Model
Antonella Delmestri
Favorite
(138) The risks of immune- and inflammatory related post-acute sequelae of COVID-19: a network study in 6 European countries, the US, and Korea
Antonella Delmestri
Favorite
(161) DARWIN EU® - Real-World Evaluation of Pulmonary Arterial Hypertension Treatment and Outcomes in Europe
Antonella Delmestri
Favorite
(247) DARWIN EU® - Characterization of Patients with Chronic Hepatitis B and C
Antonella Delmestri
Favorite
(314) Treatment of systemic lupus erythematosus: analysis of treatment patterns in adult and paediatric patients across four European countries
Antonella Delmestri
Favorite
(321) DARWIN EU® - Background Rates of Outcomes of Interest in Patients with Severe Asthma
Antonella Delmestri
Favorite
(ASPOT48) Discontinuation of preventative treatments in older people with complex health needs: self-controlled case series analyses of preventable cardiovascular events
Antonella Delmestri
Favorite
(BSPOT33) Natural history of dermatomyositis and polymyositis in adults and paediatric populations: a network cohort study part of DARWIN EU®
Antonella Delmestri
Favorite
(CSPOT33) Incidence, Prevalence, and Survival of Breast Cancer in the United Kingdom from 2000-2021: A Population-Based Cohort Study
Antonella Delmestri
Favorite
Delseny, Dominique

University of Montpellier
(138) The risks of immune- and inflammatory related post-acute sequelae of COVID-19: a network study in 6 European countries, the US, and Korea
Dominique Delseny
Favorite
Deltour, Nicolas

Aetion Germany GmbH
(317) Use of European rare disease registries to describe the natural history and disease progression of Spinal Muscular Atrophy (SMA) over time
Nicolas Deltour
Favorite
Demerath, Ellen

Division of Epidemiology and Community Health, University of Minnesota School of Public Health
(153) Evaluating the Accuracy of Infant Weight and Length Measurements from Electronic Health Records for Use in Maternal Vaccination Safety Studies
Ellen Demerath
Favorite
Demoulin, Douglas

VUMC
(BSPOT02) A prospective cohort study of risk factors associated with prostate cancer incidence in predominantly low-income Black Americans
Douglas Demoulin
Favorite
Den Hond, Elly

Provincial Institute of Hygiene, Antwerp, Belgium
(275) Gabapentinoids exposure in early pregnancy and risk of congenital anomalies: an IMI ConcePTION European case-malformed control study
Elly Den Hond
Favorite
(310) Risk of congenital ocular anomaly in EUROmediCAT: Assessment of the Potential Risk of Taking Medications during Pregnancy in Europe.
Elly Den Hond
Favorite
(313) Specific congenital anomalies associated with maternal Multiple Sclerosis: A ConcePTION European case-malformed control study
Elly Den Hond
Favorite
(318) The occurrence of specific congenital anomalies associated with maternal Systemic Lupus Erythematosus: A ConcePTION Case-malformed control study in EUROmediCAT
Elly Den Hond
Favorite
Den Uil, Manon

Division Laboratories, Pharmacy and Biomedical Genetics, Clinical Pharmacy, University Medical Centre Utrecht
(104) Determining the cost-effectiveness of pre-emptive genetic testing: an umbrella review
Manon Den Uil
Favorite
Denaxas, Spiros

University College London
(005) Cohort studies on 71 different adverse health outcomes among people with atopic eczema in UK primary care data
Spiros Denaxas
Favorite
Deneer, Vera

Division Laboratories, Pharmacy and Biomedical Genetics, Clinical Pharmacy, University Medical Centre Utrecht
(104) Determining the cost-effectiveness of pre-emptive genetic testing: an umbrella review
Vera Deneer
Favorite
Deng, Jie

Optum Epidemiology
(275) Linkage of Mother and Infant Records using Commercial Claims Data within the Food and Drug Administration (FDA) Biologics Effectiveness and Safety (BEST) Initiative
Jie Deng
Favorite
Deng, Weishang

The Chinese University of Hong Kong
(075) The Use of Potentially Interacting Supplement–Drug Pairs in Adults with Type 2 Diabetes: A Large Population-Based Cohort Study in the UK Biobank
Weishang Deng
Favorite
Deng, Yalin

Brown University School of Public Health
(BSPOT01) Variation in the time to complete the primary COVID-19 vaccine series by race, ethnicity, and geography among older US adults
Yalin Deng
Favorite
Denig, Petra

Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands
(049) Hypoglycaemia Risk and Medication De-intensification in Diabetes Patients: A Cohort Study
Petra Denig
Favorite
(071) Sex Disparities in Medication Changes After Metformin Initiation are Associated With Small, Clinically Non-Relevant, Sex Differences in HbA1c Levels During Follow-up
Petra Denig
Favorite
(CSPOT28) Limited impact of Direct Healthcare Professional Communications when using optimal outcomes and appropriate study populations: a systematic review.
Petra Denig
Favorite
Dennos, Anne

Duke Clinical Research Institute
(035) Safety Events in Patients with Polyarticular-Course Juvenile Idiopathic Arthritis Exposed to Tofacitinib (Xeljanz) or Biologics: Real-World Data from the CARRA Registry
Anne Dennos
Favorite
Denny, Clark

NCBDDD, CDC
(270) Concomitant Periconceptional Opioid Medication, Alcohol, and Tobacco Use
Clark Denny
Favorite
Depmann, Martine

University Medical Center Utrecht
(284) Oral Antihypertensives in Hypertensive Pregnancy and the Association with Fetal Growth: a Population-Based Cohort Study
Martine Depmann
Favorite
Deraedt, Quentin

GSK
(332) Background Rates of Neuroinflammatory Disorders and Atrial Fibrillation – Conditions of Interest for Vaccine Safety Studies
Quentin Deraedt
Favorite
Deramus, Thomas

Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, Harvard Medical School
(200) Scalable Natural Language Processing for Large-Scale Covariate Adjustment in Healthcare Database Studies
Thomas Deramus
Favorite
Derksen, Shelley

University of Manitoba
(263) Antiseizure medication use during pregnancy and the Risk of adverse neonatal birth outcomes in two Canadian provinces
Shelley Derksen
Favorite
(274) Gabapentin Use During Pregnancy and the Risk of Adverse Neonatal Birth Outcomes in two Canadian provinces
Shelley Derksen
Favorite
Dermiki-Gkana, Foteini

Democritus University of Thrace
(CSPOT32) Impact of risk communication on thrombosis with thrombocytopenia syndrome for COVID-19 adenovirus vector vaccines on European healthcare professionals
Foteini Dermiki-Gkana
Favorite
Dernie, Francesco

University of Oxford
(029) Prevalence of dermatomyositis and polymyositis in adults and paediatric populations: a network cohort study part of DARWIN EU®
Francesco Dernie
Favorite
(071) Discontinuation of bisphosphonates in older people with complex health needs: self-controlled case series to assess fracture risk
Francesco Dernie
Favorite
(124) Incidence and Complications of Rectopexy in the United Kingdom and United States, 2013-2022.
Francesco Dernie
Favorite
(297) Use of systemic fluoroquinolones in primary care and hospital settings in the UK: A population-level cohort study
Francesco Dernie
Favorite
(314) Treatment of systemic lupus erythematosus: analysis of treatment patterns in adult and paediatric patients across four European countries
Francesco Dernie
Favorite
(ASPOT48) Discontinuation of preventative treatments in older people with complex health needs: self-controlled case series analyses of preventable cardiovascular events
Francesco Dernie
Favorite
(BSPOT33) Natural history of dermatomyositis and polymyositis in adults and paediatric populations: a network cohort study part of DARWIN EU®
Francesco Dernie
Favorite
DerSarkissian, Maral

Analysis Group, Inc., Los Angeles, CA
(070) NALIRIFOX versus FOLFOX as first-line treatment of metastatic pancreatic ductal adenocarcinoma (mPDAC): Real-world comparative overall (OS) survival analysis
Maral DerSarkissian
Favorite
(108) Impact of Treatment of COVID-19 with Sotrovimab on Post-Acute COVID-19 Syndrome: An Analysis of National COVID Cohort Collaborative (N3C) Data
Maral DerSarkissian
Favorite
(342) Final Results from Post-Emergency Use Authorization (EUA) Active Safety Surveillance Study among Individuals in the Veterans Affairs Health System Receiving Pfizer-BioNTech Coronavirus Disease 2019 (COVID-19) Vaccine
Maral DerSarkissian
Favorite
Des Marais, Andrea

Duke University
(203) Association of opioid and benzodiazepine co-prescribing with adverse events among older adults with cancer
Andrea Des Marais
Favorite
Desai, Shaina

Aetion, Inc
(150) Characterizing device and treatment of patients with deep dermal or full thickness thermal burns in the National Burn Registry between 2021-2023
Shaina Desai
Favorite
Desalegn, Anteneh Assefa

Department of Pharmacy, University of Oslo
(344) Interim results from the VAC4EU Post-Authorization Safety Study (PASS) among recipients of the Pfizer-BioNTech COVID-19 (Comirnaty®) vaccine in Europe
Anteneh Assefa Desalegn
Favorite
(367) VAC4EU study to identify risk factors and characterize the clinical course of myocarditis/pericarditis following mRNA-1273 vaccination in four European countries: first descriptive analyses
Anteneh Assefa Desalegn
Favorite
Désaméricq, Gaëlle

Amgen SAS, Courbevoie, France
(011) Characteristics and treatment sequences of patients with KRAS G12C, other KRAS and KRAS-wild-type advanced or metastatic (AM) Non-Small Cell Lung Cancer (NSCLC) in the French ESME cohort
Gaëlle Désaméricq
Favorite
(205) Osteoporosis treatment patterns in France: A Clustering Analysis of the SNDS PMO Cohort Study
Gaëlle Désaméricq
Favorite
Descalzo-Gallego, Miguel Angel

Research Unit. Fundacion Piel Sana AEDV, Madrid, Spain
(009) Drug survival and safety of biosimilars compared with originator adalimumab for Psoriasis: a multinational cohort study
Miguel Angel Descalzo-Gallego
Favorite
Deshazo, Jonathan

CVS Health
(100) Trends in Clinical Characteristics and Prescribing Patterns for GLP-1 Receptor Agonists and GIPs, 2015–2023
Jonathan Deshazo
Favorite
(316) The IMEDS Distributed Database Network and Pregnancy Studies
Jonathan Deshazo
Favorite
(358) Safety Monitoring of Bivalent COVID-19 mRNA Vaccines Among Recipients 6 months and Older in the United States
Jonathan Deshazo
Favorite
(CSPOT20) Adherence Differences Between Self-Administered and Provider-Administered Biologics Among Patients with Rheumatoid Arthritis During the COVID-19 National Emergency
Jonathan Deshazo
Favorite
Deshpande, Saniya

Lane Clark and Peacock LLP
(177) Development and Clinical Validation of a Generative AI Assisted Medication-Indication Knowledge Base
Saniya Deshpande
Favorite
(ASPOT12) External validation using real world data of a generative AI assisted medication-indication knowledge base
Saniya Deshpande
Favorite
DeSilva, Malini

Pregnancy and Child Health Research Center, HealthPartners Institute
(123) Racial and language disparities in initial COVID-19 vaccination during lactation
Malini DeSilva
Favorite
(274) Language and racial disparities in initial COVID-19 vaccination during pregnancy
Malini DeSilva
Favorite
(299) Pregnant persons' perceptions of RSV vaccination during pregnancy
Malini DeSilva
Favorite
Desouki, Haidy

College of Pharmacy, Qatar University, Doha, Qatar
(022) Impact of Mobile Health (mHealth) Technologies on Medication Adherence and Symptoms Improvement in Patients Receiving Oral Anti-Cancer Agents: A Systematic Review
Haidy Desouki
Favorite
Desplas, David

EPI-PHARE
(CSPOT40) Use and Outcomes of Trastuzumab Deruxtecan in HER2-positive and HER2-low Metastatic Breast Cancer in Real-World Setting: A Nationwide Cohort Study
David Desplas
Favorite
Despres, Johanna

Real World Solutions, IQVIA
(344) Effectiveness Of Pertussis Vaccines In Children Between 2013 And 2019 In France: A Nested Matched Case Control Study Using The National Health Data System
Johanna Despres
Favorite
Devine, Francesca

Komodo Health
(112) Racial Disparities in Breast Cancer Management Pre- and Post-COVID-19: Unmet Needs in Health Equity
Francesca Devine
Favorite
(266) Characteristics and Depression Severity Among Pregnant Women by Antidepressant Use During Pregnancy
Francesca Devine
Favorite
Devine, Joshua

Des Moines University, Department of Public Health
(100) Drug Shortages in the U.S. and Canada Prior to and During the COVID-19 Pandemic: A Multi-National, Cross-Sectional Study
Joshua Devine
Favorite
Dewi, Ni Made Amelia Ratnata

Institute of Clinical Pharmacy, Faculty of Pharmacy, University of Szeged
(228) Trends of Triptans Use in Hungary
Ni Made Amelia Ratnata Dewi
Favorite
Deygas, Floriane

PELyon
(191) Healthcare resource use (HRU) of patients with active relapsing multiple sclerosis (RMS) using data linkage between a phase IV study and the France's national health data system.
Floriane Deygas
Favorite
Dhalwani, Nafeesa

Center for Observational Research, Amgen Inc
(142) A multi-country, observational study of high-risk pre-event cardiovascular patients: design and analytical framework
Nafeesa Dhalwani
Favorite
(197) Using negative control outcomes in trial emulation to assess the comparability of patients initiating proprotein convertase subtilisin/kexin type 9 inhibitor monoclonal antibodies following myocardial infarction
Nafeesa Dhalwani
Favorite
Dhanda, Sandeep

Drug Safety Research Unit
(333) Case Series Analysis of Immune-Mediated Neurological Events in Vaccinees following AZD1222 (ChAdOx1 nCoV-19): Results from a UK Post-authorisation Active Surveillance Study
Sandeep Dhanda
Favorite
(338) Cumulative Rates of Serious and Adverse Events of Special Interest in Vaccinees Following AZD1222 (ChAdOx1 nCoV-19): Results from a UK Post-authorisation Active Surveillance Study
Sandeep Dhanda
Favorite
(349) Observed versus Expected Analysis of Adverse Events of Special Interest after AZD1222 (ChAdOx1 nCoV-19) Vaccination: Results from a UK Post-authorisation Active Surveillance Study
Sandeep Dhanda
Favorite
Dharia, Priyadarshani

Moderna, Inc.
(102) Evaluation of postmenopausal hemorrhage following Moderna COVID-19 vaccines: results from surveillance data analysis and interim results from a US claims database cohort study
Priyadarshani Dharia
Favorite
(128) Safety of Moderna mRNA-1273.214 and mRNA-1273.222 COVID-19 bivalent vaccines: results from post-marketing surveillance in South Korea
Priyadarshani Dharia
Favorite
(129) Safety of Moderna’s mRNA-1273.222 bivalent omicron-containing vaccine: interim results from a US claims database cohort study
Priyadarshani Dharia
Favorite
Dholaria, Bhagirathbhai

Vanderbilt University
(072) Patterns of Underreporting of Enrollment Dates in Cancer Clinical Trials: A HemOnc Knowledgebase Analysis
Bhagirathbhai Dholaria
Favorite
Dhopeshwarkar, Neil

TriNetX, LLC
(084) A Cohort Study to Evaluate the Real-World Utilization and Effectiveness of Bebtelovimab Compared to Nirmatrelvir/Ritonavir among Patients with Mild-to-Moderate COVID-19 Who Are at High Risk for Progressing to Severe Illness
Neil Dhopeshwarkar
Favorite
(086) Assessing the Robustness of Comparative Effectiveness Studies: An Applied Example Evaluating the Effectiveness of Bebtelovimab In COVID-19
Neil Dhopeshwarkar
Favorite
Di Donato, Michael

6. Healthy Working Lives Research Group, School of Public Health and Preventive Medicine, Monash University
(217) Patterns of opioid doses to compensated Australian workers with low back pain
Michael Di Donato
Favorite
di Giuseppe, Romina

IQVIA, Real World Solutions, Germany.
(287) Paternal exposure to valproate and the risk of Neuro-Developmental Disorders in offspring: a population-based cohort study in Denmark, Norway and Sweden
Romina di Giuseppe
Favorite
Di Meglio, Antonio

Cancer Survivorship Program - INSERM Unit 981 Molecular predictors and new targets in oncology - Gustave Roussy, Villejuif, France
(CSPOT40) Use and Outcomes of Trastuzumab Deruxtecan in HER2-positive and HER2-low Metastatic Breast Cancer in Real-World Setting: A Nationwide Cohort Study
Antonio Di Meglio
Favorite
Diallo, Fatoumata Binta

National Public Health Institute of Quebec
(243) Prevalence and Patterns of ADHD Medication Use Among Children, Adolescents, and Young Adults: A Two-decade Analysis
Fatoumata Binta Diallo
Favorite
Diav-Citrin, Orna

The Israeli Teratology Information Service, Ministry of Health, Jerusalem, Israel; The Hebrew University and Hadassah Medical School, Jerusalem, Israel
(308) Reproductive safety of glucagon-like peptide 1 receptor agonists (GLP1-RA) after maternal exposure in early pregnancy: a comparative ENTIS cohort study
Orna Diav-Citrin
Favorite
Diaz-Decaro, John

Moderna
(208) Using large language models with real world data to support regulatory decision-making for medicinal products: Are we on the road to regulatory convergence or chaos?
John Diaz-Decaro
Favorite
Diaz, Rodrigo

Johnson & Johnson
(BSPOT14) All Enabling Technology is not created equal: comparing outcomes of computer assisted fluoroscopic hip navigation versus robotic-assisted total hip arthroplasty
Rodrigo Diaz
Favorite
DiBello, Julia

Merck & Co., Inc.
(030) Prevalence, characteristics, and prescription pain medication use in the rheumatoid arthritis population
Julia DiBello
Favorite
(337) Prevalence, characteristics, and prescription pain medication use in the osteoarthritis population
Julia DiBello
Favorite
(340) Self-reported physical functioning in patients with chronic low back pain (CLBP)
Julia DiBello
Favorite
DiCesare, Elyse

Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital and Harvard Medical School
(092) Comparing Healthcare Utilization and Cost in Empagliflozin vs GLP-1RA Initiators with Type 2 Diabetes without Established Cardiovascular Disease
Elyse DiCesare
Favorite
(147) Development and Validation of a Novel Tool to Predict Hemoglobin A1c among Patients with Type 2 Diabetes, Using Administrative Claims Data
Elyse DiCesare
Favorite
(272) Incidence of pregnancy among publicly and commercially insured childbearing-age women with warfarin treatment
Elyse DiCesare
Favorite
Dickinson, Harriet

Gilead
(208) Using large language models with real world data to support regulatory decision-making for medicinal products: Are we on the road to regulatory convergence or chaos?
Harriet Dickinson
Favorite
(BSPOT03) Advancing Health Equity in Europe: A Framework of Diversity and Fairness in Pharmacoepidemiologic Research
Harriet Dickinson
Favorite
(BSPOT07) What we owe to patients: A systematic literature review into reporting of potential biases in clinical decision support tools that use AI to personalise care in viral hepatitis
Harriet Dickinson
Favorite
Dickman, Paul

Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Sweden
(186) Flexible parametric survival models for simultaneous estimation on multiple timescales: an application using nationwide Swedish register data
Paul Dickman
Favorite
Didden, Eva-Maria

Johnson & Johnson
(163) Methodological framework to conduct outcome validation in administrative or insurance claims and/or electronic healthcare record databases: a practical guide for pharmacoepidemiologists
Eva-Maria Didden
Favorite
(ASPOT03) The Value of Large Population-based Electronic Health Record and Insurance Claims Databases for Real-World Evidence Generation in Rare Diseases: a Systematic Literature Review
Eva-Maria Didden
Favorite
(BSPOT28) How far can we go with Federated Meta-Analytic Approaches in Rare Diseases and Special Populations: A Case Example in Pediatric Pulmonary Arterial Hypertension for Regulatory Purposes
Eva-Maria Didden
Favorite
Didelez, Vanessa

Leibniz Institute for Prevention Research and Epidemiology - BIPS
(009) Breast cancer recurrence due to avoidable drug-drug interactions? Developing a protocol for a target trial in women with breast cancer who concurrently use tamoxifen and antidepressants
Vanessa Didelez
Favorite
Diehl, Annette

Pfizer Inc.
(035) Safety Events in Patients with Polyarticular-Course Juvenile Idiopathic Arthritis Exposed to Tofacitinib (Xeljanz) or Biologics: Real-World Data from the CARRA Registry
Annette Diehl
Favorite
Diessner, Brandon

Optum
(347) Interim Utilization Results from a Post-Approval Safety Study of Pfizer-BioNTech Monovalent COVID-19 Vaccine in the United States
Brandon Diessner
Favorite
Diezi, Leonore

Swiss Teratogen Information Service and Clinical Pharmacology Service, Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne, Lausanne, Switzerland
(308) Reproductive safety of glucagon-like peptide 1 receptor agonists (GLP1-RA) after maternal exposure in early pregnancy: a comparative ENTIS cohort study
Leonore Diezi
Favorite
DiFrancesco, Matthew

Brigham and Women's Hospital
(287) EHR-based pragmatic trial evaluating the impact of simulation intervention on high-risk prescribing to older adults by junior physicians
Matthew DiFrancesco
Favorite
Diiulio, Julie

Applied Decision Science
(206) Design Process for a Machine-Learning Opioid Overdose Prediction and Risk Stratification E-Tool in Electronic Health Record System
Julie Diiulio
Favorite
Dillenseger, Anja

Zentrum für klinische Neurowissenschaften an der Neurologischen Universitätsklinik Dresden
(192) Impact of the disability status of patients with multiple sclerosis on healthcare resource utilization and the ability to work: An analysis of the MSDS-AOK PLUS Linked Database
Anja Dillenseger
Favorite
Dillon, Allison

Genesis Research
(145) Unraveling the use of diagnostic tests for mild cognitive impairment, Alzheimer’s disease, and other dementias: a real-world study
Allison Dillon
Favorite
Dimaguila, Gerardo Luis

Epi-Informatics, Centre for Health Analytics, Melbourne Children's Campus, Victoria, Australia
(361) Sex Inequity in Access to Safe Vaccination: A Sex Disaggregated Comparative Analysis of Vaccine Safety Surveillance Reports and Social Media Vaccine-Related Health Mentions.
Gerardo Luis Dimaguila
Favorite
Dimakos, Jenny

McGill University
(143) A Population-Based Assessment of the Use of Oral Anticoagulants and the Risk of Major Bleeding Among Patients with Non-Valvular Atrial Fibrillation Treated With Antiarrhythmics
Jenny Dimakos
Favorite
(ASPOT32) Concomitant use of direct oral anticoagulants and pharmacokinetically-interacting antiarrhythmics and the risk of major bleeding in patients with non-valvular atrial fibrillation: population-based cohort study
Jenny Dimakos
Favorite
DiNunzio, Nina

Harvard Pilgrim Health Care Inc
(316) The IMEDS Distributed Database Network and Pregnancy Studies
Nina DiNunzio
Favorite
Dinur, Tama

Gaucher Unit, Shaare Zedek Medical Center, Jerusalem, Israel
(307) Long-term Safety and Effectiveness of Taliglucerase-alfa for Gaucher disease (GD): An International, Prospective 10-Year Follow Up Drug Registry Study (TALIAS)
Tama Dinur
Favorite
Dionne, Clermont

Université Laval
(219) What motivates patients with chronic musculoskeletal pain to use medical cannabis as a treatment strategy? Results from a questionnaire study.
Clermont Dionne
Favorite
Dipak, Kalra

PresidThe European Institute for Innovation through Health Data
(028) Overview of regulations for INN prescribing and substitution, with implications for the implementation of crossborder ePrescription and eDIspensation services in countries of the European Union.
Kalra Dipak
Favorite
DiPaula, Bethany

University of Maryland, Baltimore
(207) Disenrollment Among Commercially-Insured Individuals in the United States with Opioid Use Disorder, 2010-2019
Bethany DiPaula
Favorite
(208) Early Opioid Use Disorder Treatment Pathways and Determinants Among the Commercially-Insured, 2010-2019
Bethany DiPaula
Favorite
DiPrete, Bethany

Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
(202) Association Between Rapid Opioid Dose Tapering and Polydrug Overdose Death Among High-dose, Long-term Opioid Therapy Recipients in North Carolina Between 2006-2018
Bethany DiPrete
Favorite
DiSantostefano, Rachael

Johnson & Johnson
(136) A systematic review of algorithms used to identify neurodevelopmental disorders in electronic healthcare databases
Rachael DiSantostefano
Favorite
Diseko, Modiegi

Botswana Harvard Partnership
(231) A Target Trial of Pre-conception Switch from a Legacy Medication to a New Medication – An Application to Antiretroviral Therapy and Birth Outcomes
Modiegi Diseko
Favorite
Dixon, Ruth

Carelon Research
(BSPOT41) Current Applications of Machine Learning for Causal Inference in Healthcare Research using Observational Data
Ruth Dixon
Favorite
Dixon, William

University of Manchester
(216) Patterns of inpatient opioid trajectories following major or orthopaedic surgery
William Dixon
Favorite
(331) Comparative risk of mortality in new users of prescription opioids for non-cancer pain: results from the International Pharmacosurveillence Study
William Dixon
Favorite
Djibo, Djeneba Audrey

CVS Health
(100) Trends in Clinical Characteristics and Prescribing Patterns for GLP-1 Receptor Agonists and GIPs, 2015–2023
Djeneba Audrey Djibo
Favorite
(254) Enhancing US Lyme Disease Detection in Claims Data: Identifying Acute and Disseminated Disease
Djeneba Audrey Djibo
Favorite
(261) Framework for Public-Private Partnerships for Real-World Data Exchange of Immunizations Records for Public Health Surveillance
Djeneba Audrey Djibo
Favorite
(275) Linkage of Mother and Infant Records using Commercial Claims Data within the Food and Drug Administration (FDA) Biologics Effectiveness and Safety (BEST) Initiative
Djeneba Audrey Djibo
Favorite
(347) Interim Utilization Results from a Post-Approval Safety Study of Pfizer-BioNTech Monovalent COVID-19 Vaccine in the United States
Djeneba Audrey Djibo
Favorite
(358) Safety Monitoring of Bivalent COVID-19 mRNA Vaccines Among Recipients 6 months and Older in the United States
Djeneba Audrey Djibo
Favorite
(CSPOT20) Adherence Differences Between Self-Administered and Provider-Administered Biologics Among Patients with Rheumatoid Arthritis During the COVID-19 National Emergency
Djeneba Audrey Djibo
Favorite
Djordjevic, Steven

University of Technology Sydney
(ASPOT33) Antimicrobial Resistance Patterns of Escherichia coli urine isolates in the greater Sydney community from 2008 to 2018: a Geospatial Analysis
Steven Djordjevic
Favorite
(ASPOT35) Geographical visualization of Antibiotic use and Escherichia coli Antibiotic resistance Patterns in the greater Sydney community from 2016 to 2018
Steven Djordjevic
Favorite
(ASPOT39) Antimicrobial Resistance of Escherichia coli and Anti-diabetics: A Multi-year Geospatial Analysis
Steven Djordjevic
Favorite
Dlamini, Sipho

Division of Infectious Disease and HIV Medicine, University of Cape Town
(BSPOT51) Signal Monitoring for Adverse Events Following Immunization with COVID-19 Vaccines During the SARS-CoV-2 Pandemic: An Evaluation of the South African Surveillance System
Sipho Dlamini
Favorite
Dobbles, Michael

egnite, Inc.
(151) Case Study With a Cardiovascular Outcomes Trial for a Glucagon-Like Peptide-1 Receptor Agonist: Evaluating Trial Generalizability With an Enriched Electronic Health Record-Based Database
Michael Dobbles
Favorite
Dodd, Caitlin

Panalgo
(110) Postpartum Depression and Infant Vaccination Completion: A Real-World Data and Health Equity Perspective
Caitlin Dodd
Favorite
(306) Incident Treatment and Adverse Liver Outcomes among Patients with Primary Sclerosing Cholangitis: An Analysis of Real-World Data
Caitlin Dodd
Favorite
(ASPOT08) Towards a Framework to Describe Diversity of Real-World Data Sources: Findings from the DIVERSE Initiative
Caitlin Dodd
Favorite
Dodge, Laura

Optum Epidemiology
(267) Characteristics of perinatal depression screening and trend over time in a commercial, US-based administrative claims database
Laura Dodge
Favorite
(281) Neonatal Intensive Care Unit Services among Commercially Insured Infants in the United States, 2016 – 2023
Laura Dodge
Favorite
Do, Duy

Truveta, Inc.
(031) Real-World Patterns in Treatment Switching to Biosimilar Adalimumab in the United States
Duy Do
Favorite
(097) Real-World Patterns in GLP-1 RA Switching from 2018-2023 in the US
Duy Do
Favorite
(162) Decreased Hazard of Potassium Lowering Drug Prescription Receipt Following Implementation of the 2021 CKD-EPI Creatinine GFR Equation
Duy Do
Favorite
Dodwell, David

OUH
(064) Incidence and risk of secondary myelodysplastic syndrome and acute myeloid leukaemia in ovarian cancer patients treated with poly-ADP ribose polymerase inhibitors in England
David Dodwell
Favorite
Doherty, Brett

Carelon Research
(168) Outcome Validation to Assess Misclassification Bias in Studies Using Electronic Healthcare Claims
Brett Doherty
Favorite
Doherty, Michael

Optum Epidemiology
(267) Frequency of diagnosis codes for infant outcomes appearing on maternal health insurance claims
Michael Doherty
Favorite
(276) Linkage of Pregnancies and Infants to Potential Male Parents in a Health Insurance Claims Database
Michael Doherty
Favorite
(281) Neonatal Intensive Care Unit Services among Commercially Insured Infants in the United States, 2016 – 2023
Michael Doherty
Favorite
(324) Use of migraine medications during pregnancy and among women of childbearing age
Michael Doherty
Favorite
(327) Use of Weight-Loss Medications Among Pregnant People in the Optum Research Database
Michael Doherty
Favorite
Dolin, Paul

AstraZeneca, Cambridge, UK
(024) Mortality in an Eosinophilic Granulomatosis with Polyangiitis (EGPA) Incident Cohort: A Retrospective Study in England
Paul Dolin
Favorite
Dolk, Helen

School of Medicine, Ulster University, Belfast, United Kingdom
(275) Gabapentinoids exposure in early pregnancy and risk of congenital anomalies: an IMI ConcePTION European case-malformed control study
Helen Dolk
Favorite
(310) Risk of congenital ocular anomaly in EUROmediCAT: Assessment of the Potential Risk of Taking Medications during Pregnancy in Europe.
Helen Dolk
Favorite
(313) Specific congenital anomalies associated with maternal Multiple Sclerosis: A ConcePTION European case-malformed control study
Helen Dolk
Favorite
(318) The occurrence of specific congenital anomalies associated with maternal Systemic Lupus Erythematosus: A ConcePTION Case-malformed control study in EUROmediCAT
Helen Dolk
Favorite
Dolor, Aaron

Flatiron Health
(142) Assessing the potential value of commercial mortality data combined with publicly available death data for pharmacoepidemiology research
Aaron Dolor
Favorite
Domènech, Eugeni

Gastroenterology Dpment, Hospital Universitari Germans Trias i Pujol, Universitat Autònoma de Barcelona, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Spain
(CSPOT17) A post-authorization safety study of golimumab in ulcerative colitis using the Spanish ENEIDA registry (MK8259-042)
Eugeni Domènech
Favorite
Domenicali, Marco

Department of Medical and Surgical Sciences, University of Bologna
(292) Knowledge and Barriers in Medication Adherence and Prescription Appropriateness Tools: A Cross-Sectional Study in Clinical Practice
Marco Domenicali
Favorite
Dona', Daniele

Division of Paediatric Infectious Diseases, Department for Women’s and Children’s Health, University of Padua, Padua, Italy
(284) Retrospective Cross-Sectional Study Assessing Adverse Events And Treatment Failure In Pediatric Hemato-Oncological Patients Receiving Posaconazole (Off-label) Or Liposomal Amphotericin B Prophylaxis
Daniele Dona'
Favorite
(329) A Population Database Analysis To Estimate The Varicella Vaccine Effectiveness In Children <14 Years In A High Vaccination Coverage Area From 2004 To 2022
Daniele Dona'
Favorite
Donahoo, William T

University of Florida
(117) Glucagon-Like Peptide-1 Receptor Agonists and Risk of Parkinson’s Disease in U.S. Older Adults with Type 2 Diabetes: A Population-Based Cohort Study
William T Donahoo
Favorite
(118) Glucagon-Like Peptide-1 Receptor Agonists and Risk of Suicide/Self-harm in U.S. Older Adults with Type 2 Diabetes: A Population-Based Cohort Study
William T Donahoo
Favorite
Donahue, Elizabeth

PPD, Part of Thermo Fisher Scientific
(310) Retrospective Chart Review Data Collection to Generate External Comparator Arm Populations: Considerations and Suggestions for Reducing Key Biases
Elizabeth Donahue
Favorite
(CSPOT44) Planned and Ongoing EMA-mandated Post-approval Observational Studies of Cell & Gene Therapies (CGT): What Can We Learn from Study Characteristics?
Elizabeth Donahue
Favorite
Donald, Sarah

University of Otago
(321) Uptake of prescription smoking cessation pharmacotherapies during pregnancy: a population-based utilisation study across Australia, New Zealand, Norway, and Sweden
Sarah Donald
Favorite
Donati, Monia

Department of Medical and Surgical Sciences, University of Bologna
(292) Knowledge and Barriers in Medication Adherence and Prescription Appropriateness Tools: A Cross-Sectional Study in Clinical Practice
Monia Donati
Favorite
Donato, Bonnie M. Korenblat

Boehringer Ingelheim Pharmaceuticals, Inc.
(116) Case-Identifying Algorithms of Chronic Kidney Disease for Real-World Evidence Research: A Targeted Literature Review
Bonnie M. Korenblat Donato
Favorite
Donegan, Katherine

Medicines and Healthcare products Regulatory Agency
(124) Incidence and Complications of Rectopexy in the United Kingdom and United States, 2013-2022.
Katherine Donegan
Favorite
(199) Proof-of-concept for a UK federated data network using the OMOP common data model: the UK regulatory studyathon
Katherine Donegan
Favorite
(297) Use of systemic fluoroquinolones in primary care and hospital settings in the UK: A population-level cohort study
Katherine Donegan
Favorite
Dong, Diane

Department of Veterans Affairs
(119) Performance of the US Food and Drug Administration’s COVID-19 Disease Severity Categorization for Use in Real-World Data
Diane Dong
Favorite
(ASPOT01) Validity of the ICD-10-CM diagnosis code to identify patients with COVID-19 in Medicare administrative claims data
Diane Dong
Favorite
Dongfeng, Li

First Affiliated Hospital of XinJiang Medical University
(245) Comparative Effectiveness of Single-Drug Versus Vancomycin-based Combination Antimicrobial Regimens in Post-Neurosurgical Infections at a Northwest China Hospital
Li Dongfeng
Favorite
Dong, Shujie

Peking University Third Hospital
(BSPOT47) The Effect of Sodium Glucose Cotransporter-2 Inhibitors on HbA1c Variability and Acute Kidney Injury: A Causal Mediation Analysis
Shujie Dong
Favorite
Dong, Sijia

Global Epidemiology, Office of Chief Medical Officer, Johnson & Johnson, China
(300) Antipsychotics in treatment of adolescents with schizophrenia in China
Sijia Dong
Favorite
Dong, Wentian

Peking University Sixth Hospital, Peking University Institute of Mental Health, NHC Key Laboratory of Mental Health (Peking University), National Clinical Research Center for Mental Disorders (Peking University Sixth Hospital), Beijing 100191, China
(300) Antipsychotics in treatment of adolescents with schizophrenia in China
Wentian Dong
Favorite
(CSPOT05) Effect of long-acting injectable antipsychotics on treatment adherence and healthcare utilization in Chinese patients with schizophrenia: 1-year mirror-image study
Wentian Dong
Favorite
Dong, Yaa-Hui

Department of Pharmacy, College of Pharmaceutical Sciences, National Yang Ming Chiao Tung University, Taipei, Taiwan
(326) Sex differences in the risk of exacerbations among patients with chronic obstructive pulmonary disease: a population-based cohort study
Yaa-Hui Dong
Favorite
(ASPOT04) Use of Fluoroquinolones and Risk of Rhegmatogenous Retinal Detachment: A Retrospective Cohort Study Using Two National Representative Claims Data
Yaa-Hui Dong
Favorite
Donneyong, Macarius

The Ohio State University
(087) Anticoagulant Deprescribing After An Emergency Department Visit Due To Gastrointestinal Bleeding Among Older Patients Using Multiple Medications
Macarius Donneyong
Favorite
(ASPOT36) A Data-driven Approach to Unravelling the Contextual Social Determinants of Racial/Ethnic Health Disparities in Nonadherence to Antihypertensive Medications
Macarius Donneyong
Favorite
Donohue, Julie

Department of Health Policy and Management, Graduate School of Public Health, University of Pittsburgh
(ASPOT05) Untangling National Medicaid Data: 30 Data Quality Metrics to Support Maternal Health Studies in Two Common Data Models
Julie Donohue
Favorite
Doró, Péter

Institution of Clinical Pharmacy, University of Szeged, Szeged, Hungary
(147) Antiplatelet Drug Utilization Trends in Hungary from 2012 to 2022
Péter Doró
Favorite
Dore, David

Exponent, Inc.
(168) Evaluating the Cardiovascular Safety of Naltrexone/Bupropion in the United States
David Dore
Favorite
Dormuth, Colin

University of British Columbia
(118) Patient factors associated with effectiveness of nirmatrelvir and ritonavir in prevention of Covid-19 hospitalization or death
Colin Dormuth
Favorite
(230) A pragmatic randomized trial assessing the impact of peer comparison and therapeutic recommendations on antibiotic prescribing patterns of family physicians for uncomplicated lower urinary tract infections
Colin Dormuth
Favorite
Dornig, Sabine

AOK PLUS
(192) Impact of the disability status of patients with multiple sclerosis on healthcare resource utilization and the ability to work: An analysis of the MSDS-AOK PLUS Linked Database
Sabine Dornig
Favorite
Do, Rose

Acumen LLC
(352) Safety of Ancestral Monovalent BNT162b2 (Pfizer-BioNTech), mRNA-1273 (Moderna), and NVX-CoV2373 (Novavax) COVID-19 Vaccines in US Children Aged 6 months to 17 years
Rose Do
Favorite
dos Santos Natividade, Marcio

Federal University of Bahia
(057) Spatial-Temporal Patterns In Biologic Prescriptions For Inflammatory Bowel Diseases In The Public Healthcare System In Brazil
Marcio dos Santos Natividade
Favorite
dos Santos, Bárbara

Faculty of Pharmacy, Federal University of Minas Gerais, Belo Horizonte, MG, Brazil
(001) Advancements in Rheumatoid Arthritis Management: An Analysis of Clinical Features and Treatment Outcomes in a Brazilian Cohort
Bárbara dos Santos
Favorite
Doshi, Amit

Mercy St Louis
(ASPOT11) Evaluation of ablation workflow for Paroxysmal and Persistent Atrial Fibrillation Treatment using electronic health record linked with digital health data
Amit Doshi
Favorite
dosReis, Susan

University of Maryland School of Pharmacy
(194) Risk Of Cardiovascular Events Among Youths And Young Adults With Concomitant Use Of Atypical Antipsychotics With Antidepressants
Susan dosReis
Favorite
(CSPOT07) Factors Associated with Adherence to Long-Acting Injectable Antipsychotics Among Medicare Beneficiaries
Susan dosReis
Favorite
(CSPOT39) Trajectories of Antidepressant Use After Tamoxifen Initiation Among Young and Middle Age Women with Breast Cancer
Susan dosReis
Favorite
Douarin, Ludivine

Sanofi
(021) How to improve Patient centricity in Benefit-Risk Assessments (BRA)?
Ludivine Douarin
Favorite
Douladiri, Christina

Laboratory of Hygiene and Environmental Protection, School of Medicine, Democritus University of Thrace, Aexandroupolis, Greece
(224) Study of utilization of oral contraceptive drugs & relevant perceptions of general population in Greece with the use of a questionnaire
Christina Douladiri
Favorite
Douros, Antonios

Institute of Clinical Pharmacology and Toxicology, Charité - Universitätsmedizin Berlin, Berlin, Germany
(069) Safety of concomitant use of antidiabetic drugs and oral anticoagulants: a systematic review of observational studies
Antonios Douros
Favorite
(143) A Population-Based Assessment of the Use of Oral Anticoagulants and the Risk of Major Bleeding Among Patients with Non-Valvular Atrial Fibrillation Treated With Antiarrhythmics
Antonios Douros
Favorite
(ASPOT30) The prevalent new-user design to study drug-drug interactions: the example of sulfonylureas and warfarin interaction on the risk of severe hypoglycemia
Antonios Douros
Favorite
(ASPOT32) Concomitant use of direct oral anticoagulants and pharmacokinetically-interacting antiarrhythmics and the risk of major bleeding in patients with non-valvular atrial fibrillation: population-based cohort study
Antonios Douros
Favorite
(BSPOT03) Advancing Health Equity in Europe: A Framework of Diversity and Fairness in Pharmacoepidemiologic Research
Antonios Douros
Favorite
Downes, Kat

PPD, part of Thermo Fisher Scientific
(347) Methodological considerations for the design and implementation of real-world vaccine-related studies in low- and middle-income countries
Kat Downes
Favorite
Dragan, Roxana

University of Manitoba
(263) Antiseizure medication use during pregnancy and the Risk of adverse neonatal birth outcomes in two Canadian provinces
Roxana Dragan
Favorite
(274) Gabapentin Use During Pregnancy and the Risk of Adverse Neonatal Birth Outcomes in two Canadian provinces
Roxana Dragan
Favorite
(301) Prenatal Exposure to Gabapentin and the Risk of Autism Spectrum Disorder in Children
Roxana Dragan
Favorite
Dragut, Claudia

Teva
(280) Pregnancy and Fetal Outcomes after Maternal Exposure to Glatiramer Acetate – an Updated Analysis
Claudia Dragut
Favorite
Draper, Brian

UNSW Sydney
(200) Age-related risk of serious fall events associated with opioid analgesic use
Brian Draper
Favorite
Dray-Spira, Rosemary

EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), 143-147 Boulevard Anatole France, 93285, Saint-Denis, France
(221) Levonorgestrel-releasing Intrauterine Systems And Copper Intrauterine Devices Utilization In France: Changes From The Last Decade
Rosemary Dray-Spira
Favorite
(246) Changes in the Use of Carbamazepine Before, During and After Pregnancy: A Nationwide Study in France between 2013 and 2021
Rosemary Dray-Spira
Favorite
(253) COVID-19 vaccination rate among pregnant women in France: a nationwide study
Rosemary Dray-Spira
Favorite
(303) Prevalence of major congenital malformations in France between 2010 and 2021: estimates among the 9 millions children and foetuses of the EPI-MERES register and relevance for perinatal pharmacoepidemiology
Rosemary Dray-Spira
Favorite
(339) Eighteen-month follow-up cohort study of post-vaccination COVID-19 myocarditis in France compared with other forms of myocarditis
Rosemary Dray-Spira
Favorite
Dreischulte, Tobias

Institute of General Practice and Family Medicine, University Hospital, LMU Munich, Munich
(130) PARTNER pilot study: Interprofessional clinical pathway to patient-oriented deprescribing of psychotropic and anticholinergic medications in elderly patients with polypharmacy
Tobias Dreischulte
Favorite
(149) Development of Algorithms for the Implementation and Detection of Adverse Events in Routine Electronic Data Sources
Tobias Dreischulte
Favorite
(158) Identification of Valid Indicators for the Detection of Potentially Adverse Drug Event-Related Hospitalisations in Routine Electronic Data Sources: a RAND Survey
Tobias Dreischulte
Favorite
(186) Who Should Be Prioritised For Primary Care Medication Review? Consensus Validation And Point Prevalence of Explicit Prescribing Indicators
Tobias Dreischulte
Favorite
(209) Potentially drug-related emergency hospital admissions and their influence on patient's long-term medication. Analysis of administrative data from a Scottish Database.
Tobias Dreischulte
Favorite
(210) Prevalence and Predictors for potentially Adverse Drug Event-related Hospitalisations
Tobias Dreischulte
Favorite
(216) Deprescribing of antidepressants: Development of indicators of high-risk and overprescribing using the RAND/UCLA Appropriateness Method
Tobias Dreischulte
Favorite
(ASPOT18) Antidepressant long-term and potential high-risk prescribing in two Scottish health boards: a cross-sectional analysis
Tobias Dreischulte
Favorite
(ASPOT43) Fall risk increasing adverse reactions (FRIARs) and fracture risk: A nested case control study
Tobias Dreischulte
Favorite
Dresco, Isabelle

Sanofi, France.
(013) Effectiveness of additional risk minimisation measures for valproate among healthcare professionals and patients: a cross-sectional survey in six European countries
Isabelle Dresco
Favorite
(287) Paternal exposure to valproate and the risk of Neuro-Developmental Disorders in offspring: a population-based cohort study in Denmark, Norway and Sweden
Isabelle Dresco
Favorite
(320) Therapeutic strategies after discontinuation of valproate in clinical practice in women with bipolar disorder: a cohort study in the United Kingdom and France databases
Isabelle Dresco
Favorite
(321) Therapeutic strategies after discontinuation of valproate in clinical practice in women with epilepsy: a cohort study in the United Kingdom and France databases
Isabelle Dresco
Favorite
Dreyer, Nancy

Dreyer Strategies
(161) Linking clinical trial participants to their U.S. real-world data through tokenization: a practical guide
Nancy Dreyer
Favorite
Dreyfus, Jill

Pfizer, Inc
(357) The Use of Background Incidence Rates to Support Vaccine Safety Monitoring: Challenges and Future Opportunities in the Framework of Beyond COVID Monitoring Excellence (BeCOME)
Jill Dreyfus
Favorite
Drey, Michael

Department of Medicine IV, Geriatrics, University Hospital, Ludwig-Maximilians-Universität Munich, Munich 80336, Germany
(ASPOT43) Fall risk increasing adverse reactions (FRIARs) and fracture risk: A nested case control study
Michael Drey
Favorite
Drnach, Alek

WorkPartners, LLC
(169) Exploration of Reason Codes in Real World Cardiovascular System Short-term Disability Claims in the United States
Alek Drnach
Favorite
(189) Disability and Workers’ Compensation Absences Associated with Major Depressive Disorder and the Overlap with Family Medical Leaves Among US Employees
Alek Drnach
Favorite
(223) Modeling Medical, Prescription, Disability, and Absence Costs for Employees with Major Depressive Disorder (MDD): Using Shorter Pre-Index Time Periods for Charlson Comorbidity Indexes (CCI) and Smaller Sample Sizes
Alek Drnach
Favorite
(223) Real World Retrospective Analysis of Short-term Disability Claims for Genitourinary System Conditions in the United States
Alek Drnach
Favorite
Dronkers, Esther

LOGEX Healthcare analytics, Amsterdam, The Netherlands
(BSPOT43) Real-world overall survival after alternative dosing for pembrolizumab in the treatment of non-small cell lung cancer: a nationwide retrospective cohort study with a non-inferiority primary objective.
Esther Dronkers
Favorite
Drouin, Jérôme

EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), 143-147 Boulevard Anatole France, 93285, Saint-Denis, France
(246) Changes in the Use of Carbamazepine Before, During and After Pregnancy: A Nationwide Study in France between 2013 and 2021
Jérôme Drouin
Favorite
(253) COVID-19 vaccination rate among pregnant women in France: a nationwide study
Jérôme Drouin
Favorite
(303) Prevalence of major congenital malformations in France between 2010 and 2021: estimates among the 9 millions children and foetuses of the EPI-MERES register and relevance for perinatal pharmacoepidemiology
Jérôme Drouin
Favorite
(339) Eighteen-month follow-up cohort study of post-vaccination COVID-19 myocarditis in France compared with other forms of myocarditis
Jérôme Drouin
Favorite
Droz-Perroteau, Cécile

Bordeaux PharmacoEpi, INSERM CIC-P 1401, Université de Bordeaux
(331) Active Safety Monitoring of COVID-19 Vaccines in France using Patient-Reported Outcomes
Cécile Droz-Perroteau
Favorite
Drucker, Aaron

Division of Dermatology, Department of Medicine, University of Toronto
(206) Patient characteristics associated with Topical Calcineurin Inhibitor Discontinuation: A retrospective cohort study
Aaron Drucker
Favorite
Druelles, Sophie

Epidemiology and Real-World Science, Parexel
(CSPOT29) Assessing use of the Reporting recommendation Intended for pharmaceutical Risk Minimization Evaluation Studies (RIMES) checklist in risk minimization evaluation studies in the EUPAS register
Sophie Druelles
Favorite
Druet Cabanac, Annie

SERVIER
(311) Generalized anxiety disorder: Epidemiology, burden, and comorbid depression.
Annie Druet Cabanac
Favorite
(335) Natural history of knee osteoarthritis with regards to other joint sites and knee replacement: a population-based cohort study in the UK Clinical Practice Research Datalink (CPRD)
Annie Druet Cabanac
Favorite
Druga, Devarapalli Ranjani

Niper Guwahati
(043) “Effect Of Pharmacological Interventions On Liver Function Parameters In Patients With NAFLD/NASH: A Systematic Review and Network meta-Analysis”
Devarapalli Ranjani Druga
Favorite
Drummond, Paula

Ezequiel Dias Foundation
(058) First-line therapy discontinuation among Brazilian multiple myeloma patients: incidence and reasons
Paula Drummond
Favorite
(240) Off-label use of thalidomide in pediatric patients with Crohn's disease and other subtypes of inflammatory bowel disease: a literature review
Paula Drummond
Favorite
Drysdale, Myriam

GSK, Brentford, Middlesex
(108) Impact of Treatment of COVID-19 with Sotrovimab on Post-Acute COVID-19 Syndrome: An Analysis of National COVID Cohort Collaborative (N3C) Data
Myriam Drysdale
Favorite
du Toit, Clea

University of Glasgow
(184) Patterns and Determinants of Adherence to Medication Guideline in Myocardial Infarction (MI) Survivors: A Retrospective Cohort Study of 21,510 patients
Clea du Toit
Favorite
Dua, Anisha

Northwestern University
(149) Characteristics Associated with Long-Term Glucocorticoid Use in Patients with New Onset Polymyalgia Rheumatica
Anisha Dua
Favorite
Duarte-Salles, Talita

Erasmus MC and IDIAPJGol
(029) Prevalence of dermatomyositis and polymyositis in adults and paediatric populations: a network cohort study part of DARWIN EU®
Talita Duarte-Salles
Favorite
(133) Prescription Sequence Symmetry Analysis to Identify Prescription Cascades for Dementia Drug Treatments in the United Kingdom
Talita Duarte-Salles
Favorite
(138) The risks of immune- and inflammatory related post-acute sequelae of COVID-19: a network study in 6 European countries, the US, and Korea
Talita Duarte-Salles
Favorite
(314) Treatment of systemic lupus erythematosus: analysis of treatment patterns in adult and paediatric patients across four European countries
Talita Duarte-Salles
Favorite
(315) Treatments of multiple myeloma in Europe from 2012 to 2022: a population-based network cohort study
Talita Duarte-Salles
Favorite
(321) DARWIN EU® - Background Rates of Outcomes of Interest in Patients with Severe Asthma
Talita Duarte-Salles
Favorite
(BSPOT33) Natural history of dermatomyositis and polymyositis in adults and paediatric populations: a network cohort study part of DARWIN EU®
Talita Duarte-Salles
Favorite
(CSPOT33) Incidence, Prevalence, and Survival of Breast Cancer in the United Kingdom from 2000-2021: A Population-Based Cohort Study
Talita Duarte-Salles
Favorite
Duberstein, Paul

Rutgers, the State University of New Jersey
(198) Predicting survival using geriatric assessment (GA) in older adults with advanced cancer using least absolute selection and shrinkage operator (LASSO)
Paul Duberstein
Favorite
Dube, Sabada

Epidemiology, Vaccines and Immune Therapies Unit, AstraZeneca
(088) Capturing Information Not Presented in Hazard Ratios: The Added Value of Presenting Plots of Instantaneous Hazards for Time-To-Event Analyses
Sabada Dube
Favorite
Dublin, Sascha

Kaiser Permanente Washington Health Research Institute
(254) Development of a Pregnancy Cohort in Commercial Insurance Claims Data: Evaluation of Inpatient Versus Apparent Outpatient Deliveries
Sascha Dublin
Favorite
Dubucs, Charlotte

CERPOP, Inserm U1295, Université de Toulouse Paul Sabatier, Service de Pharmacologie Clinique, CHU de Toulouse
(310) Risk of congenital ocular anomaly in EUROmediCAT: Assessment of the Potential Risk of Taking Medications during Pregnancy in Europe.
Charlotte Dubucs
Favorite
Duchemin, Tom

RE-MEDs
(195) Systematic emulation trials to evaluate the real-world effectiveness of multiple sclerosis treatments
Tom Duchemin
Favorite
Du, Chengxiang

Global Epidemiology, Janssen Research & Development, LLC, Beijing, China
(015) Discordance between clinical and pathological stage in non-small cell lung cancer patients in China
Chengxiang Du
Favorite
(CSPOT05) Effect of long-acting injectable antipsychotics on treatment adherence and healthcare utilization in Chinese patients with schizophrenia: 1-year mirror-image study
Chengxiang Du
Favorite
Duchesneau, Emilie

Department of Epidemiology and Prevention, Wake Forest School of Medicine
(035) Assessing the utility of claims for haemoglobin A1c performance measures in characterizing glycemic control in older adult Medicare beneficiaries with diabetes.
Emilie Duchesneau
Favorite
(129) Older US adults refilling potentially inappropriate medications after hip fracture
Emilie Duchesneau
Favorite
(143) The prevalent new-user study design: a novel application to estimating the average treatment effect of statin discontinuation on mortality among traditional Medicare beneficiaries who discontinued statins
Emilie Duchesneau
Favorite
(BSPOT05) Interpreting Effect Estimates Across Racial and Ethnic Categories in Propensity Score-Based Analyses: An Application in US Medicare Beneficiaries Initiating Antidiabetic Medications
Emilie Duchesneau
Favorite
Duckworth, Samantha

Epidemiology and Real-World Science, Parexel
(CSPOT29) Assessing use of the Reporting recommendation Intended for pharmaceutical Risk Minimization Evaluation Studies (RIMES) checklist in risk minimization evaluation studies in the EUPAS register
Samantha Duckworth
Favorite
Dudukina, Elena

Danish Medicines Agency
(273) Gabapentin in Pregnancy and Birth Outcomes: a Population-based Prevalence Study in Nordic Countries (EUPAS38620)
Elena Dudukina
Favorite
(332) Associations Between the Latest Received Dose of mRNA COVID-19 Vaccine Product and Chronic or Other Types of Urticaria: Nationwide Registry-Based Cohort Study in Denmark
Elena Dudukina
Favorite
Du, Fanxing

University of Florida College of Pharmacy
(146) Use of Immunomodulators/Biologics is protective against Major Adverse Cardiovascular Events in Medicare patients with Inflammatory Bowel Disease over use of 5-ASA alone.
Fanxing Du
Favorite
Dugré, Nicolas

Université de Montréal
(014) Experiences and perceptions of patients and healthcare professionals with advanced practice partnership agreements between Family Medicine Group pharmacists and healthcare professionals
Nicolas Dugré
Favorite
Duh, Mei Sheng

Analysis Group, Inc., Boston, MA
(070) NALIRIFOX versus FOLFOX as first-line treatment of metastatic pancreatic ductal adenocarcinoma (mPDAC): Real-world comparative overall (OS) survival analysis
Mei Sheng Duh
Favorite
(108) Impact of Treatment of COVID-19 with Sotrovimab on Post-Acute COVID-19 Syndrome: An Analysis of National COVID Cohort Collaborative (N3C) Data
Mei Sheng Duh
Favorite
(342) Final Results from Post-Emergency Use Authorization (EUA) Active Safety Surveillance Study among Individuals in the Veterans Affairs Health System Receiving Pfizer-BioNTech Coronavirus Disease 2019 (COVID-19) Vaccine
Mei Sheng Duh
Favorite
Duke, Jon

Georgia Tech Research Institute
(ASPOT05) Untangling National Medicaid Data: 30 Data Quality Metrics to Support Maternal Health Studies in Two Common Data Models
Jon Duke
Favorite
Duk, Tessa

Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, The Netherlands
(191) Sex differences in dispensed cardiovascular medication in primary care
Tessa Duk
Favorite
Duma, Nathan

Acumen LLC
(362) Stroke Risk Following Receipt of High-Dose/Adjuvanted Influenza Vaccinations Among U.S. Adults Aged ≥65 Years; 2016-2019
Nathan Duma
Favorite
Du, Mike

Nuffield Department of Orthopaedics, Centre for Statistics in Medicine , Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK
(314) Treatment of systemic lupus erythematosus: analysis of treatment patterns in adult and paediatric patients across four European countries
Mike Du
Favorite
Dundas, Ruth

University of Glasgow
(184) Patterns and Determinants of Adherence to Medication Guideline in Myocardial Infarction (MI) Survivors: A Retrospective Cohort Study of 21,510 patients
Ruth Dundas
Favorite
Duong, Hong

Inserm
(252) Covid19 Vaccination During Pregnancy: a Descriptive Study of Uptake and Safety for Mothers and Infants Using the Nationwide French National Health System
Hong Duong
Favorite
Duong, Mai

Evidera
(202) Systematic Definition Development of Variables of Interest for Studies Using Administrative Databases
Mai Duong
Favorite
Durán, Carlos

Department of Data Science and Biostatistics, University Medical Center Utrecht
(154) Fit-for-purpose evaluation of Real-World Data for vaccines and medicines safety studies: the INSIGHT tool
Carlos Durán
Favorite
(279) Maternal outcomes in women receiving COVID-19 vaccination during pregnancy compared with influenza vaccines in spontaneous reporting databases
Carlos Durán
Favorite
(ASPOT08) Towards a Framework to Describe Diversity of Real-World Data Sources: Findings from the DIVERSE Initiative
Carlos Durán
Favorite
Durand, Étienne

Université Laval
(286) Description of interventions performed by pharmacists involved in the care of older adults with neurocognitive disorders in family medicine groups in Quebec, Canada
Étienne Durand
Favorite
Durant, Audrey

Laval University
(BSPOT23) Evaluating performance and methodologies of machine learning and conventional pharmacoepidemiologic modeling to identify pregnant individuals at risk of giving birth to children with major congenital malformations
Audrey Durant
Favorite
Duranteau, Lise

APHP
(226) Use of progestogens and the risk of intracranial meningioma: a national case-control study
Lise Duranteau
Favorite
Dureau-Pournin, Caroline

Bordeaux PharmacoEpi, INSERM CIC-P 1401, Université de Bordeaux
(331) Active Safety Monitoring of COVID-19 Vaccines in France using Patient-Reported Outcomes
Caroline Dureau-Pournin
Favorite
Durkin, Michael

Washington University School of Medicine
(171) Quantifying the impact of different look-back period criteria to identify new users when medication adherence is poor: A study of chronic medications for opioid use disorder
Michael Durkin
Favorite
(254) Development of a Pregnancy Cohort in Commercial Insurance Claims Data: Evaluation of Inpatient Versus Apparent Outpatient Deliveries
Michael Durkin
Favorite
Duskin-Bitan, Hadar

Clalit Community Division, Clalit Health Services
(088) Capturing Information Not Presented in Hazard Ratios: The Added Value of Presenting Plots of Instantaneous Hazards for Time-To-Event Analyses
Hadar Duskin-Bitan
Favorite
Dutcher, Sarah

Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration
(097) COVID-19 Related Changes in Healthcare Utilization Among Insured Persons in the US and its Impact on Pharmacoepidemiologic Research
Sarah Dutcher
Favorite
(231) Characterizing inpatient electronic health records (EHR) from a large hospital network for use in neonatal pharmacoepidemiology studies in the United States
Sarah Dutcher
Favorite
(302) Prenatal syphilis in the US: characterizing screening and treatment during pregnancy in publicly and commercially insured individuals
Sarah Dutcher
Favorite
(ASPOT05) Untangling National Medicaid Data: 30 Data Quality Metrics to Support Maternal Health Studies in Two Common Data Models
Sarah Dutcher
Favorite
Duxbury, Michael

Amgen
(142) A multi-country, observational study of high-risk pre-event cardiovascular patients: design and analytical framework
Michael Duxbury
Favorite
Dwan, Bernadette

IQVIA
(085) An Assessment of Use and Comparative Safety of GLP-1 Receptor Agonists in the Real-world Setting, 2017-2023
Bernadette Dwan
Favorite
(213) An Assessment of Use and Emerging Safety of Esketamine Nasal Spray in the U.S., 2019-2023
Bernadette Dwan
Favorite
Dwivedi, Akshat

P95 Epidemiology & Pharmacovigilance
(352) Quantifying Bias in COVID-19 Vaccine Effectiveness (VE) Estimates Due to Missing Information on Prior SARS-CoV-2 Infection: an Assessment Using Data from the European COVIDRIVE Study
Akshat Dwivedi
Favorite